Yale Cancer Center investigators show recommended, but underused, treatment for rare blood cancer saves lives
MD Linx US and European guidelines on treating polycythemia vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is ... |
from phlebotomy - Google News http://bit.ly/2qwyLRx
No comments:
Post a Comment